AVIR R&D Expenses
Atea Pharmaceuticals Inc · R&D Expenses
AVIR R&D Expenses
Latest reported$155.45Mperiod ending
AVIR TTM R&D Expenses ($10.17M → $155.45M)
TTM R&D Expenses
High-resolution chart · PNG
AVIR r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 155,449,000 | |
| 159,574,000 | |
| 148,024,000 | |
| 125,877,000 | |
| 113,689,000 | |
| 116,110,000 | |
| 144,101,000 | |
| 153,475,000 | |
| 159,245,000 | |
| 154,489,000 | |
| 126,868,000 | |
| 120,463,000 | |
| 93,439,000 | |
| 83,357,000 | |
| 83,881,000 | |
| 113,052,000 | |
| 151,166,000 | |
| 171,111,000 | |
| 167,204,000 | |
| 123,239,000 | |
| 93,821,000 | |
| 61,773,000 | |
| 38,023,000 | |
| 27,666,000 | |
| 16,476,000 | |
| 11,547,000 | |
| 10,170,000 |